Skip to the main content

Professional paper

Have Skin Biopsy Results in Adults Been Affected in the COVID-19 Pandemic?

Emine Çölgeçen ; Department of Dermatology and Venereology, School of Medicine, Yozgat Bozok University, Yozgat, Turkey
Gözde Emel Gökçek ; Department of Dermatology and Venereology, School of Medicine, Yozgat Bozok University, Yozgat, Turkey
Sevinç Şahin ; Department of Pathology, School of Medicine, Alanya Alaaddin Keykubat University, Antalya, Turkey


Full text: english pdf 207 Kb

page 40-48

downloads: 289

cite


Abstract

The purpose of this study was to assess how skin biopsy results from adults, which occupy an important place in dermatological practice, have been affected by the COVID-19 pandemic. Adult patients aged over 18 presenting to the dermatology clinical of a tertiary hospital between March 12, 2019 and March 11, 2020, and between March 12, 2020 and March 11, 2021, from whom skin biopsies had been taken and who had undergone pathological examination were included in the study. Pre-COVID-19 pandemic data were compared with post-pandemic data. No significant difference was determined between the two periods in terms of age, sex, type of biopsy, preliminary diagnosis numbers, or clinicopathological correlation (P>0.05). The diseases most frequently diagnosed through biopsy before the pandemic were psoriasis (13.7%), pseudopelade of Brocq (6.8%), and fibroepithelial polyp (5.5%), compared with psoriasis (9.4%), basal cell carcinoma (BCC) (6.3%), lichen planus (6.3%), and urticarial vasculitis (6.3%) during the pandemic. Diagnoses of BCC and urticarial vasculitis were significantly elevated after the COVID-19 pandemic (P<0.05), while no periodic difference was observed in other diagnoses. A rise in the incidence of various diseases, such as urticarial vasculitis, may be indicative of a risk of asymptomatic COVID-19. Further polymerase chain reaction and/or antibody-based investigations should be carried out in order to establish whether dermatological diseases are associated with asymptomatic COVID-19 cases. Determining the clinical and histopathological aspects of COVID-19, which can progress with various cutaneous findings, will be useful in the early diagnosis and treatment of this novel and life-threatening disease.

Keywords

biopsy; clinicopathological correlation; COVID-19; dermatology, pathology

Hrčak ID:

280108

URI

https://hrcak.srce.hr/280108

Publication date:

1.4.2022.

Visits: 857 *